Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Assessment and Syndrome Evolution Models Combining Traditional Chinese Medicine and Modern Medicine Indicators for Chronic Atrophic Gastritis Malignant Transformation: a Registry Study

NCT03261934 is registered in ClinicalTrials.gov with Beijing University of Chinese Medicine as lead sponsor.

NCT NCT03261934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03261934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Assessment and Syndrome Evolution Models Combining Traditional Chinese Medicine and Modern Medicine Indicators for Chronic Atrophic Gastritis Malignant Transformation: a Registry Study
Lead sponsor
Beijing University of Chinese Medicine
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2018
Completion date
December 31, 2030
Enrollment
2,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

risk assessment of chronic atrophic gastritis malignant transformation